× Industry Reports Services Press Release Contact us About us

Asia Pacific Compounding Pharmacies Market Size By Therapeutic Area (Hormone Replacement, Pain Management, Dermatology Applications, Specialty Drugs, Nutritional Supplements), By Product (Oral {Solid Preparations [Tablets, Capsules, Granules, Powder], Liquid Preparations [Solutions, Suspension, Emulsion, Syrup], Topical [Ointments, Creams, Gels, Pastes], Rectal [Suppositories, Enema], Parenteral [LVP, SVP]}, Nasal, Ophthalmic, Otic), By Application (Pediatric, Adult, Geriatric, Veterinary), By Compounding Type (Pharmaceutical Ingredient Alteration [PIA], Currently Unavailable Pharmaceutical Manufacturing [CUPM], Pharmaceutical Dosage Alteration [PDA]), By Sterility (Sterile, Non-sterile), By Distribution Channel (Hospital Pharmacy, Compounding Pharmacy), Industry Analysis Report, Regional Outlook (Japan, China, India, Singapore, Australia, Taiwan, South Korea, Indonesia, Thailand), Application Potential, Competitive Market Share & Forecast, 2020 - 2026

Published Date: January 2021 | Publisher: Graphical Research Report ID: GR1603 | Delivery : PDF

Report Content

Chapter 1   Methodology

1.1    Definition and forecast parameters

1.1.1    Definitions

1.1.2    Methodology and forecast parameters

1.2    Data sources

1.3    References & sources

1.3.1    Secondary

1.3.2    Primary

Chapter 2   Executive Summary

2.1    Asia Pacific compounding pharmacies industry summary, 2015 - 2026

2.1.1    Country trends

2.1.2    Therapeutic trends

2.1.3    Product trends

2.1.4    Application trends

2.1.5    Compounding type trends

2.1.6    Sterility trends

2.1.7    Distribution channel trends

Chapter 3   Industry Insights

3.1    Industry segmentation

3.2    Industry outlook, 2015 - 2026

3.3    Major factor analysis

3.3.1    Drivers

3.3.1.1    Rising geriatric population and improved life expectancy

3.3.1.2    Rising adoption of customized medicine

3.3.1.3    Shortage of drugs

3.3.1.4    Benefits of compounded medication

3.3.1.5    Growing drug failure rate

3.3.2    Restraints & challenges

3.3.2.1    High cost of equipment and maintenance of sterile environment

3.3.2.2    Volatile regulatory scenario

3.3.2.3    Consumer perception towards compounded drugs

3.4    Regulatory landscape

3.4.1    Australia

3.5    Reimbursement landscape

3.5.1    Australia

3.6    COVID-19 impact analysis

3.7    Porter’s analysis

3.8    Competitive review, 2019

3.9    PEST analysis

Chapter 4   Asia Pacific Compounding Pharmacies Market Size, By Therapeutic Area

4.1    Key trends in Asia Pacific compounding pharmacies, by therapeutic area

4.2    Hormone replacement

4.2.1    Market estimates and forecast, by country, 2015 - 2026 (USD Million)

4.3    Pain management

4.3.1    Market estimates and forecast, by country, 2015 - 2026 (USD Million)

4.4    Dermatology

4.4.1    Market estimates and forecast, by country, 2015 - 2026 (USD Million)

4.5    Specialty drugs

4.5.1    Market estimates and forecast, by country, 2015 - 2026 (USD Million)

4.6    Nutritional supplements

4.6.1    Market estimates and forecast, by country, 2015 - 2026 (USD Million)

4.7    Others

4.7.1    Market estimates and forecast, by country, 2015 - 2026 (USD Million)

Chapter 5   Asia Pacific Compounding Pharmacies Market Share, By Product

5.1    Key trends in Asia Pacific compounding pharmacies, by product

5.2    Oral

5.2.1    Market estimates and forecast, by country, 2015 - 2026 (USD Million)

5.2.2    Solid preparations

5.2.2.1    Market estimates and forecast, by country, 2015 - 2026 (USD Million)

5.2.2.2    Tablets

5.2.2.2.1    Market estimates and forecast, by country, 2015 - 2026 (USD Million)

5.2.2.3    Capsules

5.2.2.3.1    Market estimates and forecast, by country, 2015 - 2026 (USD Million)

5.2.2.4    Granules

5.2.2.4.1    Market estimates and forecast, by country, 2015 - 2026 (USD Million)

5.2.2.5    Powder

5.2.2.5.1    Market estimates and forecast, by country, 2015 - 2026 (USD Million)

5.2.2.6    Others

5.2.2.6.1    Market estimates and forecast, by country, 2015 - 2026 (USD Million)

5.2.3    Liquid preparations

5.2.3.1    Market estimates and forecast, by country, 2015 - 2026 (USD Million)

5.2.3.2    Solutions

5.2.3.2.1    Market estimates and forecast, by country, 2015 - 2026 (USD Million)

5.2.3.3    Suspension

5.2.3.3.1    Market estimates and forecast, by country, 2015 - 2026 (USD Million)

5.2.3.4    Emulsion

5.2.3.4.1    Market estimates and forecast, by country, 2015 - 2026 (USD Million)

5.2.3.5    Syrup

5.2.3.5.1    Market estimates and forecast, by country, 2015 - 2026 (USD Million)

5.2.3.6    Others

5.2.3.6.1    Market estimates and forecast, by country, 2015 - 2026 (USD Million)

5.3    Topical

5.3.1    Market estimates and forecast, by country, 2015 - 2026 (USD Million)

5.3.2    Ointments

5.3.2.1    Market estimates and forecast, by country, 2015 - 2026 (USD Million)

5.3.3    Creams

5.3.3.1    Market estimates and forecast, by country, 2015 - 2026 (USD Million)

5.3.4    Gels

5.3.4.1    Market estimates and forecast, by country, 2015 - 2026 (USD Million)

5.3.5    Pastes

5.3.5.1    Market estimates and forecast, by country, 2015 - 2026 (USD Million)

5.3.6    Others

5.3.6.1    Market estimates and forecast, by country, 2015 - 2026 (USD Million)

5.4    Rectal

5.4.1    Market estimates and forecast, by country, 2015 - 2026 (USD Million)

5.4.1.1    Suppositories

5.4.1.1.1    Market estimates and forecast, by country, 2015 - 2026 (USD Million)

5.4.1.2    Enema

5.4.1.2.1    Market estimates and forecast, by country, 2015 - 2026 (USD Million)

5.4.1.3    Others

5.4.1.3.1    Market estimates and forecast, by country, 2015 - 2026 (USD Million)

5.5    Parenteral

5.5.1    Market estimates and forecast, by country, 2015 - 2026 (USD Million)

5.5.1.1    Small volume parenteral (SVP) solutions

5.5.1.1.1    Market estimates and forecast, by country, 2015 - 2026 (USD Million)

5.5.1.2    Large Volume Parenteral (LVP) Solutions

5.5.1.2.1    Market estimates and forecast, by country, 2015 - 2026 (USD Million)

5.6    Nasal

5.6.1    Market estimates and forecast, by country, 2015 - 2026 (USD Million)

5.7    Ophthalmic

5.7.1    Market estimates and forecast, by country, 2015 - 2026 (USD Million)

5.8    Otic

5.8.1    Market estimates and forecast, by country, 2015 - 2026 (USD Million)

Chapter 6   Asia Pacific Compounding Pharmacies Market Trends, By Application

6.1    Key trends in Asia Pacific compounding pharmacies, by application

6.2    Paediatric

6.2.1    Market estimates and forecast, by country, 2015 - 2026 (USD Million)

6.3    Adult

6.3.1    Market estimates and forecast, by country, 2015 - 2026 (USD Million)

6.4    Geriatric

6.4.1    Market estimates and forecast, by country, 2015 - 2026 (USD Million)

6.5    Veterinary

6.5.1    Market estimates and forecast, by country, 2015 - 2026 (USD Million)

Chapter 7   Asia Pacific Compounding Pharmacies Market Growth, By Compounding Type

7.1    Key trends in Asia Pacific compounding pharmacies, by compounding type

7.2    Pharmaceutical Ingredient Alteration (PIA)

7.2.1    Market estimates and forecast, by country, 2015 - 2026 (USD Million)

7.3    Currently Unavailable Pharmaceutical Manufacturing (CUPM)

7.3.1    Market estimates and forecast, by country, 2015 - 2026 (USD Million)

7.4    Pharmaceutical Dosage Alteration (PDA)

7.4.1    Market estimates and forecast, by country, 2015 - 2026 (USD Million)

7.5    Others

7.5.1    Market estimates and forecast, by country, 2015 - 2026 (USD Million)

Chapter 8   Asia Pacific Compounding Pharmacies Market Report, By Sterility

8.1    Key trends in Asia Pacific compounding pharmacies, by sterility

8.2    Sterile

8.2.1    Market estimates and forecast, by country, 2015 - 2026 (USD Million)

8.3    Non-sterile

8.3.1    Market estimates and forecast, by country, 2015 - 2026 (USD Million)

Chapter 9   Asia Pacific Compounding Pharmacies Market Forecast, By Distribution Channel

9.1    Key trends in Asia Pacific compounding pharmacies, by distribution channel

9.2    Hospital pharmacy

9.2.1    Market estimates and forecast, by country, 2015 - 2026 (USD Million)

9.3    Compounding pharmacy

9.3.1    Market estimates and forecast, by country, 2015 - 2026 (USD Million)

9.4    Others

9.4.1    Market estimates and forecast, by country, 2015 - 2026 (USD Million)

Chapter 10   Asia Pacific Compounding Pharmacies Market Industry, By Country

10.1    Key trends in Asia Pacific compounding pharmacies, by country

10.2    China

10.2.1    Market estimates and forecast, by therapeutic area, 2015 - 2026 (USD Million)

10.2.2    Market estimates and forecast, by product, 2015 - 2026 (USD Million)

10.2.2.1    Market estimates and forecast, by oral, 2015 - 2026 (USD Million)

10.2.2.1.1    Market estimates and forecast, by solid preparations, 2015 - 2026 (USD Million)

10.2.2.1.2    Market estimates and forecast, by liquid preparation, 2015 - 2026 (USD Million)

10.2.2.2    Market estimates and forecast, by topical, 2015 - 2026 (USD Million)

10.2.2.3    Market estimates and forecast, by rectal, 2015 - 2026 (USD Million)

10.2.2.4    Market estimates and forecast, by parenteral, 2015 - 2026 (USD Million)

10.2.3    Market estimates and forecast by application, 2015 - 2026 (USD Million)

10.2.4    Market estimates and forecast, by compounding type, 2015 - 2026 (USD Million)

10.2.5    Market estimates and forecast, by sterility, 2015 - 2026 (USD Million)

10.2.6    Market estimates and forecast, by distribution channel, 2015 - 2026 (USD Million)

10.3    Japan

10.3.1    Market estimates and forecast, by therapeutic area, 2015 - 2026 (USD Million)

10.3.2    Market estimates and forecast, by product, 2015 - 2026 (USD Million)

10.3.2.1    Market estimates and forecast, by oral, 2015 - 2026 (USD Million)

10.3.2.1.1    Market estimates and forecast, by solid preparations, 2015 - 2026 (USD Million)

10.3.2.1.2    Market estimates and forecast, by liquid preparation, 2015 - 2026 (USD Million)

10.3.2.2    Market estimates and forecast, by topical, 2015 - 2026 (USD Million)

10.3.2.3    Market estimates and forecast, by rectal, 2015 - 2026 (USD Million)

10.3.2.4    Market estimates and forecast, by parenteral, 2015 - 2026 (USD Million)

10.3.3    Market estimates and forecast by application, 2015 - 2026 (USD Million)

10.3.4    Market estimates and forecast, by compounding type, 2015 - 2026 (USD Million)

10.3.5    Market estimates and forecast, by sterility, 2015 - 2026 (USD Million)

10.3.6    Market estimates and forecast, by distribution channel, 2015 - 2026 (USD Million)

10.4    India

10.4.1    Market estimates and forecast, by therapeutic area, 2015 - 2026 (USD Million)

10.4.2    Market estimates and forecast, by product, 2015 - 2026 (USD Million)

10.4.2.1    Market estimates and forecast, by oral, 2015 - 2026 (USD Million)

10.4.2.1.1    Market estimates and forecast, by solid preparations, 2015 - 2026 (USD Million)

10.4.2.1.2    Market estimates and forecast, by liquid preparation, 2015 - 2026 (USD Million)

10.4.2.2    Market estimates and forecast, by topical, 2015 - 2026 (USD Million)

10.4.2.3    Market estimates and forecast, by rectal, 2015 - 2026 (USD Million)

10.4.2.4    Market estimates and forecast, by parenteral, 2015 - 2026 (USD Million)

10.4.3    Market estimates and forecast by application, 2015 - 2026 (USD Million)

10.4.4    Market estimates and forecast, by compounding type, 2015 - 2026 (USD Million)

10.4.5    Market estimates and forecast, by sterility, 2015 - 2026 (USD Million)

10.4.6    Market estimates and forecast, by distribution channel, 2015 - 2026 (USD Million)

10.5    Singapore

10.5.1    Market estimates and forecast, by therapeutic area, 2015 - 2026 (USD Million)

10.5.2    Market estimates and forecast, by product, 2015 - 2026 (USD Million)

10.5.2.1    Market estimates and forecast, by oral, 2015 - 2026 (USD Million)

10.5.2.1.1    Market estimates and forecast, by solid preparations, 2015 - 2026 (USD Million)

10.5.2.1.2    Market estimates and forecast, by liquid preparation, 2015 - 2026 (USD Million)

10.5.2.2    Market estimates and forecast, by topical, 2015 - 2026 (USD Million)

10.5.2.3    Market estimates and forecast, by rectal, 2015 - 2026 (USD Million)

10.5.2.4    Market estimates and forecast, by parenteral, 2015 - 2026 (USD Million)

10.5.3    Market estimates and forecast by application, 2015 - 2026 (USD Million)

10.5.4    Market estimates and forecast, by compounding type, 2015 - 2026 (USD Million)

10.5.5    Market estimates and forecast, by sterility, 2015 - 2026 (USD Million)

10.5.6    Market estimates and forecast, by distribution channel, 2015 - 2026 (USD Million)

10.6    Australia

10.6.1    Market estimates and forecast, by therapeutic area, 2015 - 2026 (USD Million)

10.6.2    Market estimates and forecast, by product, 2015 - 2026 (USD Million)

10.6.2.1    Market estimates and forecast, by oral, 2015 - 2026 (USD Million)

10.6.2.1.1    Market estimates and forecast, by solid preparations, 2015 - 2026 (USD Million)

10.6.2.1.2    Market estimates and forecast, by liquid preparation, 2015 - 2026 (USD Million)

10.6.2.2    Market estimates and forecast, by topical, 2015 - 2026 (USD Million)

10.6.2.3    Market estimates and forecast, by rectal, 2015 - 2026 (USD Million)

10.6.2.4    Market estimates and forecast, by parenteral, 2015 - 2026 (USD Million)

10.6.3    Market estimates and forecast by application, 2015 - 2026 (USD Million)

10.6.4    Market estimates and forecast, by compounding type, 2015 - 2026 (USD Million)

10.6.5    Market estimates and forecast, by sterility, 2015 - 2026 (USD Million)

10.6.6    Market estimates and forecast, by distribution channel, 2015 - 2026 (USD Million)

10.7    Taiwan

10.7.1    Market estimates and forecast, by therapeutic area, 2015 - 2026 (USD Million)

10.7.2    Market estimates and forecast, by product, 2015 - 2026 (USD Million)

10.7.2.1    Market estimates and forecast, by oral, 2015 - 2026 (USD Million)

10.7.2.1.1    Market estimates and forecast, by solid preparations, 2015 - 2026 (USD Million)

10.7.2.1.2    Market estimates and forecast, by liquid preparation, 2015 - 2026 (USD Million)

10.7.2.2    Market estimates and forecast, by topical, 2015 - 2026 (USD Million)

10.7.2.3    Market estimates and forecast, by rectal, 2015 - 2026 (USD Million)

10.7.2.4    Market estimates and forecast, by parenteral, 2015 - 2026 (USD Million)

10.7.3    Market estimates and forecast by application, 2015 - 2026 (USD Million)

10.7.4    Market estimates and forecast, by compounding type, 2015 - 2026 (USD Million)

10.7.5    Market estimates and forecast, by sterility, 2015 - 2026 (USD Million)

10.7.6    Market estimates and forecast, by distribution channel, 2015 - 2026 (USD Million)

10.8    South Korea

10.8.1    Market estimates and forecast, by therapeutic area, 2015 - 2026 (USD Million)

10.8.2    Market estimates and forecast, by product, 2015 - 2026 (USD Million)

10.8.2.1    Market estimates and forecast, by oral, 2015 - 2026 (USD Million)

10.8.2.1.1    Market estimates and forecast, by solid preparations, 2015 - 2026 (USD Million)

10.8.2.1.2    Market estimates and forecast, by liquid preparation, 2015 - 2026 (USD Million)

10.8.2.2    Market estimates and forecast, by topical, 2015 - 2026 (USD Million)

10.8.2.3    Market estimates and forecast, by rectal, 2015 - 2026 (USD Million)

10.8.2.4    Market estimates and forecast, by parenteral, 2015 - 2026 (USD Million)

10.8.3    Market estimates and forecast by application, 2015 - 2026 (USD Million)

10.8.4    Market estimates and forecast, by compounding type, 2015 - 2026 (USD Million)

10.8.5    Market estimates and forecast, by sterility, 2015 - 2026 (USD Million)

10.8.6    Market estimates and forecast, by distribution channel, 2015 - 2026 (USD Million)

10.9    Indonesia

10.9.1    Market estimates and forecast, by therapeutic area, 2015 - 2026 (USD Million)

10.9.2    Market estimates and forecast, by product, 2015 - 2026 (USD Million)

10.9.2.1    Market estimates and forecast, by oral, 2015 - 2026 (USD Million)

10.9.2.1.1    Market estimates and forecast, by solid preparations, 2015 - 2026 (USD Million)

10.9.2.1.2    Market estimates and forecast, by liquid preparation, 2015 - 2026 (USD Million)

10.9.2.2    Market estimates and forecast, by topical, 2015 - 2026 (USD Million)

10.9.2.3    Market estimates and forecast, by rectal, 2015 - 2026 (USD Million)

10.9.2.4    Market estimates and forecast, by parenteral, 2015 - 2026 (USD Million)

10.9.3    Market estimates and forecast by application, 2015 - 2026 (USD Million)

10.9.4    Market estimates and forecast, by compounding type, 2015 - 2026 (USD Million)

10.9.5    Market estimates and forecast, by sterility, 2015 - 2026 (USD Million)

10.9.6    Market estimates and forecast, by distribution channel, 2015 - 2026 (USD Million)

10.10    Thailand

10.10.1    Market estimates and forecast, by therapeutic area, 2015 - 2026 (USD Million)

10.10.2    Market estimates and forecast, by product, 2015 - 2026 (USD Million)

10.10.2.1    Market estimates and forecast, by oral, 2015 - 2026 (USD Million)

10.10.2.1.1    Market estimates and forecast, by solid preparations, 2015 - 2026 (USD Million)

10.10.2.1.2    Market estimates and forecast, by liquid preparation, 2015 - 2026 (USD Million)

10.10.2.2    Market estimates and forecast, by topical, 2015 - 2026 (USD Million)

10.10.2.3    Market estimates and forecast, by rectal, 2015 - 2026 (USD Million)

10.10.2.4    Market estimates and forecast, by parenteral, 2015 - 2026 (USD Million)

10.10.3    Market estimates and forecast by application, 2015 - 2026 (USD Million)

10.10.4    Market estimates and forecast, by compounding type, 2015 - 2026 (USD Million)

10.10.5    Market estimates and forecast, by sterility, 2015 - 2026 (USD Million)

10.10.6    Market estimates and forecast, by distribution channel, 2015 - 2026 (USD Million)

Chapter 11   Company Profiles

11.1    B Braun Medical Inc

11.1.1    Business overview

11.1.2    Financial data

11.1.3    Product landscape

11.1.4    Strategic outlook

11.2    Fresenius Kabi

11.2.1    Business overview

11.2.2    Financial data

11.2.3    Product landscape

11.2.4    Strategic outlook

11.3    Clinigen Group PLC

11.3.1    Business overview

11.3.2    Financial data

11.3.3    Product landscape

11.3.4    Strategic outlook

11.4    Athenex Pharma Solutions (Athenex Inc

11.4.1    Business overview

11.4.2    Financial data

11.4.3    Product landscape

11.4.4    Strategic outlook

11.5    Veterinary Specialty Pharmacy

11.5.1    Business overview

11.5.2    Financial data

11.5.3    Product landscape

11.5.4    Strategic outlook

11.6    Amber Compounding Pharmacy Pte Ltd

11.6.1    Business overview

11.6.2    Financial data

11.6.3    Product landscape

11.6.4    Strategic outlook

11.7    Belle Santé Diagnostic & Therapeutic Institute Pvt Ltd

11.7.1    Business overview

11.7.2    Financial data

11.7.3    Product landscape

11.7.4    Strategic outlook

11.8    Fresh Therapeutics

11.8.1    Business overview

11.8.2    Financial data

11.8.3    Product landscape

11.8.4    Strategic outlook

11.9    Super Pharmacy

11.9.1    Business overview

11.9.2    Financial data

11.9.3    Product landscape

11.9.4    Strategic outlook

11.10    Kingsway Compounding

11.10.1    Business overview

11.10.2    Financial data

11.10.3    Product landscape

11.10.4    Strategic outlook
 


Select License

Asia Pacific Compounding Pharmacies Market - Industry Size Report 2026


Related Reports
Why Choose us?
  • On-Time Delivery - logo On-Time Delivery
  • Assured Quality - logo Assured Quality
  • Industry Experts - logo Industry Experts
  • Payment Security - logo Payment Security
Share Social-media